A molecular diagnostic test for BCR-ABL fusion gene detection. This test is used in onco-hematology for chronic myeloid leukemia (CML) diagnosis and monitoring.
Manufactured by
Padova, Italy
AB ANALITICA was established in the year 1990 in Padua in the Veneto region (north-east Italy) and is a company is specialized in the development and the sale of diagnostic systems for professional use. Through our highly qualified and committed researchers as well as constant collaboration with research institutes, universities, and hospitals we have gained the scientific knowledge and experience that allow AB ANALITICA to develop and produce high-quality, innovative and safe diagnostic systems that are in line with the most recent medical guidelines. We at AB ANALITICA are particularly aware of emerging technologies and the requirements of the diagnostic market, and are continuously investing in our research and development department, which is involved in advanced molecular biology diagnostics in microbiology, virology, oncology, and genetics. Our main competences cover diagnostics based on qualitative and quantitative determination of nucleic acids by molecular biology methods, the development and implementation of biobanking management systems as well as in vivo and in vitro diagnostics using breath test and stable isotopes. AB ANALITICA has a sales agent network that covers the entire Italian territory and we collaborate with local distributors in many export countries. AB ANALITICA is certified according to UNI EN ISO 9001 and UNI EN ISO 13485 for the design, development, production and trade of in-vitro diagnostic medical devices (IVD) in the fields of infectious diseases, in hematology, in oncology and genetic testing, in pharmacogenetics, breath tests, Next Gene Sequencing (NGS), automated solutions for sample preparation for in-vitro diagnostics as well as technical assistance for these systems. In addition AB ANALITICA markets and provides technical assistance for instruments for in-vitro diagnostics and offers laboratory services for clinical chemistry analyses. All our products for diagnostic use have been certified according to directive 98/79/EC on medical in-vitro diagnostic devices. Our product lines include: HCV genotyping kits (Hepatitis C Virus), conforming to Annex II, list A, of directive 98/79/EC End-Point PCR and Real-Time PCR kits for detection of infection markers of Chlamydia trachomatis and Cytomegalovirus, conforming to Annex II, list B, of directive 98/79/EC PCR kits for determination of genetic predisposition based on HLA typing, conforming to Annex II, list B, of directive 98/79/EC We at AB ANALITICA ensure both efficacy and optimal performance of our devices using Internal Controls and by regularly participating in External Quality Assessment programs. AB ANALITICA is also certified by the CFDA (China Food and Drug Administration) for HPV diagnostics, has registered products as ASRs (Analyte Specific Reagents) with the FDA (U.S. Food and Drug Administration) and is authorized to export in 40 different countries. Production Our in vitro diagnostics (IVD) are made in our Padua branch. Over 2400 sqm of laboratories are reserved for Production and R&D. The entire production cycle is subject to strict quality controls.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HLB PANAGENE Co., Ltd.
South Korea · 4 relevant products
TRUPCR Europe Ltd
United Kingdom · 21 relevant products
Cambrian Bioworks LLC
United States · 1 relevant product
GENERI BIOTECH s.r.o.
Czech Republic · 2 relevant products
GMA Group Trading
Egypt · 2 relevant products
Suzhou Rainsure Scientific Co., Ltd.
China · 1 relevant product
Rainsure Scientific Co. Ltd.
China · 2 relevant products
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 7 relevant products
Diatech Pharmacogenetics srl
Italy · 1 relevant product
Zeesan Biotech Co., Ltd
China · 1 relevant product
25 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 82 closest product alternatives
HLB PANAGENE Co., Ltd. · South Korea
A molecular diagnostic test for BCR-ABL fusion gene detection in chronic myeloid leukemia and acute lymphoblastic leukemia.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for qualitative detection of BCR-ABL fusion transcripts. This kit enables detection of BCR-ABL1 presence for initial diagnosis of chronic myeloid leukemia.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for quantitative measurement of BCR-ABL fusion transcripts. This kit provides absolute quantification of BCR-ABL1 levels for disease monitoring and therapeutic response assessment in chronic myeloid leukemia.
Cambrian Bioworks LLC · United States
Molecular diagnostic system for detection of BCR-ABL fusion genes from peripheral blood samples. Supports advanced hematologic malignancy diagnostics and monitoring.
GENERI BIOTECH s.r.o. · Czech Republic
Real-time PCR kit for detection of BCR-ABL fusion gene mutations in human genomic DNA. CE IVD marked diagnostic tool using fluorescently labelled probes for quantitative analysis. Intended for chronic myeloid leukemia (CML) screening and monitoring in clinical laboratory settings.
GMA Group Trading · Egypt
Real-time PCR test for detection and quantification of BCR-ABL fusion transcripts in chronic myeloid leukemia.
Suzhou Rainsure Scientific Co., Ltd. · China
Specialized digital PCR kit for quantifying BCR-ABL fusion gene p210 variant with international scale normalization. Supports monitoring and therapeutic management of chronic myeloid leukemia patients.
Rainsure Scientific Co. Ltd. · China
High-precision digital PCR assay kit for quantifying BCR-ABL(p210) to support monitoring and management of chronic myeloid leukemia patients.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Real-time PCR kit for quantitative detection and monitoring of BCR-ABL1 fusion transcript in chronic myeloid leukemia. Enables precise measurement of disease burden and treatment response assessment.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for screening and detection of BCR-ABL1 fusion transcripts. This kit is designed for initial identification of BCR-ABL1 in suspected chronic myeloid leukemia cases.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for detection of BCR-ABL1 with EAC-DEL variant status. This kit identifies specific BCR-ABL1 deletion variants relevant to chronic myeloid leukemia diagnosis and prognosis.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for differentiation of BCR-ABL1 fusion transcript variants b2a2 and b3a2. This kit enables identification of specific BCR-ABL1 breakpoint variants relevant to chronic myeloid leukemia diagnosis.
70 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products